Hallym University Gangnam Sacred Heart Hospital Adopts Non-Invasive AI Blood Flow Analysis System
"Assessing the Need for Coronary Intervention with AI in Just One Minute"
Hallym University Gangnam Sacred Heart Hospital announced on the 6th that it has introduced the AI-based coronary artery flow analysis system "μFR AngioPlus Core (Myuepeual)" to improve the safety of coronary intervention procedures and the accuracy of treatment decisions.
Professor Cho Jungrae, Department of Cardiology at Hallym University Gangnam Sacred Heart Hospital, explaining the AI coronary artery blood flow analysis system MFR. Hallym University Gangnam Sacred Heart Hospital
View original imageCoronary artery disease is a condition in which the blood vessels that supply blood and oxygen to the heart become narrowed or blocked. The challenge is that, even when a vessel appears narrowed, there are cases where there is no actual blood flow impairment, while in other cases, the narrowing may not look severe but the reduction in blood flow is significant. Therefore, in the treatment process, it is more important to accurately determine whether there is actual blood flow impairment than to focus solely on the degree of vascular stenosis.
Previously, an invasive examination was used to assess blood flow status by inserting a wire into the coronary artery and administering drugs. This process placed a significant burden on patients, and the decision on whether to perform a procedure relied heavily on the operator's experience and visual assessment, which posed limitations.
Myuepeual is a non-invasive examination system that quantifies and analyzes blood flow status within about one minute using only coronary angiography images. It can be used to determine the need for an intervention procedure without additional procedures or drug administration, making it applicable for emergency patients and high-risk patients. Another feature is that it allows simulation-based review of whether to perform stent placement and where to place the stent.
In general, when the μFR value is around 0.8, this serves as a reference for deciding between stent placement and drug treatment. Medical staff determine the treatment plan by combining this value with clinical information such as the patient's symptoms and lesion characteristics.
Cho Jeongrae, Professor of Cardiology at Hallym University Gangnam Sacred Heart Hospital, said, "We can now assess coronary artery stenosis using numerical values rather than visual estimation, which has increased the objectivity of treatment decisions," adding, "This helps reduce unnecessary procedures."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The hospital explained that the accuracy and safety of the AI-based blood flow analysis technology have been evaluated through multinational clinical studies conducted overseas. However, the specific study design and numerical results have not been released.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.